[Melatonin in correction of REM-sleep behavior disorders in Parkinson's disease].
Objective - to estimate efficacy and safety of melatonin in REM-sleep behavior disorders (RBD) in patients with Parkinson's disease (PD). We examined 60 patients with RBD and I-III stages of PD. Neuropsychological examination was performed before and after treatment. RBD was confirmed by polysomnography in 30 patients. After the treatment with melatonin in dose of 3-6 mg for 4 weeks, 84% of patients reported reduction of RBD symptoms, daytime sleepiness, anxiety and depression. Melatonin can be used for RBD treatment in PD patients.